SCHEMBL5497340

SCHEMBL5497340

CCn1c[c]c2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.34
SLC9A1 P19634 1/20 0.33
NR4A2 P43354 1/20 0.33
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
HTT P42858 3/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 3/20 0.31
BRCA1 P38398 1/20 0.31
GABRA5 P31644 1/20 0.31
CYP19A1 P11511 1/20 0.30
TBXAS1 P24557 1/20 0.30
LMNA P02545 1/20 0.30
KDM4E B2RXH2 2/20 0.30
HSD17B10 Q99714 2/20 0.30
TDP1 Q9NUW8 2/20 0.30
NSD2 O96028 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6236614 0.84 SLC9A1 (0.37) ALDH1A1SLC9A1MEN1KMT2AHTT
SCHEMBL2784532 0.81 SLC9A1 (0.40) ALDH1A1SLC9A1KDM4EHSD17B10TDP1
SCHEMBL28905062 0.80 SLC9A1 (0.41) ALDH1A1SLC9A1CYP1A2CYP2D6
SCHEMBL9581979 0.79
SCHEMBL2948314 0.79 KDM4E (0.38) ALDH1A1SMN1; SMN2MAPTLMNAKDM4E
SCHEMBL6227403 0.79 L3MBTL1 (0.34) ALDH1A1SMN1; SMN2HTTLMNAKDM4E
SCHEMBL6230861 0.79
SCHEMBL3086235 0.78 TP53 (0.38) KMT2ASMN1; SMN2HTTLMNAKDM4E
SCHEMBL11719143 0.78 SLC9A1 (0.43) ALDH1A1SLC9A1MEN1KMT2ACYP1A2
SCHEMBL8699910 0.78 SLC9A1 (0.43) ALDH1A1SLC9A1MEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113072467-B Substituted guanidino-containing derivative and application thereof in preparing osteoclast differentiation inhibitor 南方医科大学 2022-04-12 CN claimed
CN-113072467-A Substituted guanidino-containing derivative and application thereof in preparing osteoclast differentiation inhibitor 南方医科大学 2021-07-06 CN claimed
CN-112521382-A Aloe-emodin thiazolidinedione compound and preparation method and application thereof 西南大学 2021-03-19 CN claimed
CN-113072467-B Substituted guanidino-containing derivative and application thereof in preparing osteoclast differentiation inhibitor 南方医科大学 2022-04-12 CN disclosed
CN-113072467-A Substituted guanidino-containing derivative and application thereof in preparing osteoclast differentiation inhibitor 南方医科大学 2021-07-06 CN disclosed
CN-112521382-A Aloe-emodin thiazolidinedione compound and preparation method and application thereof 西南大学 2021-03-19 CN disclosed
CN-112218852-A Oxidized bis (3-indolyl) methane and uses thereof 桑福德·伯纳姆·普雷比医学发现研究所 2021-01-12 CN disclosed
CN-106928150-B Acrylamide aniline derivative and pharmaceutical application thereof 恩瑞生物医药科技(上海)有限公司 2020-07-31 CN disclosed
US-10342796-B2 Acrylanilide derivative, preparation method, and applications thereof in pharmacy ANCUREALL PHARMACEUTICAL (SHANGHAI) CO., LTD. (CN) 2019-07-09 US disclosed
US-20190015413-A1 ACRYLANILIDE DERIVATIVE, PREPARATION METHOD, AND APPLICATIONS THEREOF IN PHARMACY ANCUREALL PHARMACEUTICAL (SHANGHAI) CO., LTD. (CN) 2019-01-17 US disclosed
EP-3398939-A1 ACRYLANILIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF IN PHARMACY Ancureall Pharmaceutical (Shanghai) Co., Ltd. (CN) 2018-11-07 EP disclosed
EP-0435179-A2 Silver halide color photographic material FUJI PHOTO FILM CO., LTD. (JP) 1991-07-03 EP disclosed
EP-0426043-A2 Silver halide color photographic material and method for forming color image Fuji Photo Film Co., Ltd. (JP) 1991-05-08 EP disclosed
US-4966983-A PRESSURE OR HEAT SENSITIVE ELEMENTS BASF AKTIENGESELLSCHAFT (DE) 1990-10-30 US disclosed
US-4940703-A Spirocyclic compounds incorporating five-membered rings with two heteroatoms for treating psychotic disorders, etc. MERCK SHARP & DOHME LIMITED (GB) 1990-07-10 US disclosed
EP-0337547-A1 Spirocyclic compounds incorporating five-membered rings with two heteroatoms MERCK SHARP & DOHME LTD. (GB) 1989-10-18 EP disclosed
US-4841050-A Carbazole containing benzopyrans BASF AKTIENGESELLSCHAFT (DE) 1989-06-20 US disclosed
EP-0236973-B1 BENZOPYRANES AND THEIR USE IN A RECORDING SYSTEM BASF Aktiengesellschaft (DE) 1989-06-14 EP disclosed
EP-0236973-A2 Benzopyranes and their use in a recording system BASF Aktiengesellschaft (DE) 1987-09-16 EP disclosed
EP-0105397-B1 SULPHURIC INDOLE DERIVATIVES MERCK PATENT GmbH (DE) 1986-07-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10342796-B2 Acrylanilide derivative, preparation method, and applications thereof in pharmacy EGFR, ABL1, CSNK1A1 ALDH1A1 2848/4885SLC9A1 2457/4885NR4A2 3847/4885
US-20190015413-A1 ACRYLANILIDE DERIVATIVE, PREPARATION METHOD, AND APPLICATIONS THEREOF IN PHARMACY EGFR, ABL1, CSNK1A1 ALDH1A1 2848/4885SLC9A1 2457/4885NR4A2 3847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.